Ad
related to: chinese equivalent of fda report on pfizer drug side effectsinsights.pfizer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
In November 2021, Pfizer submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization for the co-packaged medication. [68] [69] [70] The authorization was granted in December 2021, for people aged twelve years of age or older who are infected with COVID‑19 and are at risk. [12] [18] [71]
Draft laws, regulations and rules and policy plans on the administration and supervision of food (including food additives and health food, the same below) safety, drugs (including traditional Chinese medicines and ethno-medicines, the same below), medical devices and cosmetics; formulate normative documents, and facilitate the establishment and implementation of the food safety responsibility ...
Azvudine is an antiviral drug which acts as a reverse transcriptase inhibitor. [3] It was discovered for the treatment of hepatitis C [4] and has since been investigated for use against other viral diseases such as AIDS and COVID-19, [2] [5] for which it was granted conditional approval in China.
The U.S. Food and Drug Administration (FDA) also released warnings about the risk of blood clots. [13] [14] [15] An important side effect of Jakinibs is serious bacterial, mycobacterial, fungal and viral infections. In the phase III trials of tofacitinib among opportunistic infections, pulmonary tuberculosis (TB) was reported in 3 cases all of ...
Common side effects of the vaccine listed by Pfizer-BioNTech and Moderna include those you may have when you are sick, like tiredness, headache, muscle and joint pains, chills, fever, nausea ...
Gastrointestinal side-effects lead to discontinuation of the drug in 2% to 8% of people using varenicline. [ 19 ] [ 20 ] Incidence of nausea is dose-dependent: incidence of nausea was higher in people taking a larger dose (30%) versus placebo (10%) as compared to people taking a smaller dose (16%) versus placebo (11%).
In December 2021, the U.S. Food and Drug Administration authorised the use of Paxlovid, making it the first drug for COVID-19 that can be taken at home. China, whose home-grown vaccines are seen ...
For premium support please call: 800-290-4726 more ways to reach us